Simply Wall St.27d agoneutral
How The Story Is Shifting For United States Antimony (UAMY) After The Galena Joint VentureUnited States Antimony’s latest analyst update keeps the model fair value anchored at US$12.67 per share, with no change to the central price target. That steady figure sits against mixed views, where more optimistic analysts connect their confidence to progress at the Galena Complex and planned federal funding. More cautious voices, however, point to execution, permitting, and funding risks across multiple projects. As you read on, you will see how these moving parts shape the evolving story...